Molecular Imaging of the Immune System
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (30 August 2024) | Viewed by 14821
Special Issue Editors
Interests: synthesis; inorganic chemistry; nanotechnology; macrocycles; coordination chemistry; medical imaging; transition metal; medicinal chemistry; medical and biomedical image processing; PET; radiochemistry
Interests: PET radiochemistry; drug and radiopharmaceutical discovery; clinical translation
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The development of molecular imaging agents for interrogating the immune system is an important area of research with potential applications in a variety of fields. This includes, but is not limited to, understanding inflammation and the ageing immune system (“inflammaging”), interrogating biological responses to bacterial and viral infection, as well as monitoring cancer patients’ response to immunotherapy. A greater understanding of our immune system, and tools to interrogate immune response in patients, could open possibilities for new therapeutics for a range of immune-related diseases and conditions, in addition to imaging biomarkers.
We are pleased to invite you to contribute original research articles and reviews to our Special Issue. We aim to form a collection of the latest advancements in the field and hope the Issue will transcend scientific disciplines and imaging modalities.
We look forward to receiving your contributions.
Prof. Dr. Steve J. Archibald
Dr. Louis Allott
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunotherapy
- immunology
- immune response
- probe development
- positron emission tomography (PET)
- clinical imaging
- preclinical imaging
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.